Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update"

The WHO-CHOICE (World Health Organization CHOosing Interventions that are Cost-Effective) approach is unique in the global health landscape, as it takes a "generalized" approach to cost-effectiveness analysis (CEA) that can be seen as a quantitative assessment of current and future efficie...

Full description

Saved in:
Bibliographic Details
Main Authors: Melanie Y. Bertram (Author), Tessa Tan Torres Edejer (Author)
Format: Book
Published: Kerman University of Medical Sciences, 2021-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_df8b8be2c8414dd3adda5a46fc30a13d
042 |a dc 
100 1 0 |a Melanie Y. Bertram  |e author 
700 1 0 |a Tessa Tan Torres Edejer  |e author 
245 0 0 |a Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update" 
260 |b Kerman University of Medical Sciences,   |c 2021-11-01T00:00:00Z. 
500 |a 2322-5939 
500 |a 10.34172/ijhpm.2021.105 
520 |a The WHO-CHOICE (World Health Organization CHOosing Interventions that are Cost-Effective) approach is unique in the global health landscape, as it takes a "generalized" approach to cost-effectiveness analysis (CEA) that can be seen as a quantitative assessment of current and future efficiency within a health system. CEA is a critical contribution to the process of priority setting and decision-making in healthcare, contributing to deliberative dialogue processes to select services to be funded. WHO-CHOICE provides regional level estimates of cost-effectiveness, along with tools to support country level analyses. This series provides an update to the methodological approach used in WHO-CHOICE and presents updated cost-effectiveness estimates for 479 interventions. Five papers are presented, the first focusing on methodological updates, followed by three results papers on maternal, newborn and child health; HIV, tuberculosis and malaria; and non- communicable diseases and mental health. The final paper presents a set of example universal health coverage (UHC) benefit packages selected through only a value for money lens, showing that all disease areas have interventions which can fall on the efficiency frontier. Critical for all countries is institutionalizing decisionmaking processes. A UHC benefit package should not be static, as the countries needs and ability to pay change over time. Decisions will need to be continually revised and new interventions added to health benefit packages. This is a vital component of progressive realization, as the package is expanded over time. Developing an institutionalized process ensures this can be done consistently, fairly, and transparently, to ensure an equitable path to UHC. 
546 |a EN 
690 |a cost-effectiveness analysis 
690 |a universal health coverage 
690 |a benefit package 
690 |a economics 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n International Journal of Health Policy and Management, Vol 10, Iss Special Issue on WHO-CHOICE Update, Pp 670-672 (2021) 
787 0 |n https://www.ijhpm.com/article_4139_8746f3c196d741b72cbadf8ea3c43a05.pdf 
787 0 |n https://doaj.org/toc/2322-5939 
856 4 1 |u https://doaj.org/article/df8b8be2c8414dd3adda5a46fc30a13d  |z Connect to this object online.